Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1207/s15327019eb0403_11 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR).
J Nutr Health Aging
January 2025
Faculty of Medicine and Health, School of Health Sciences and Sydney Medical School, University of Sydney, New South Wales, Australia, and Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA, United States.
Article Synopsis
- Aging leads to physiological changes and increased disease vulnerability, culminating in higher mortality rates as individuals get older.
- Regular physical activity (PA) and exercise can counteract aging effects, improve health span, and reduce the risk of chronic diseases such as heart disease and cancer.
- Personalized exercise plans, including various forms of training like aerobic and resistance exercises, are essential for maintaining health and functionality in older adults, particularly those with age-related issues.
Emerging global patterns of COVID-19 vaccine information fatigue in 23 countries in 2023.
Vaccine
December 2024
Graduate School of Public Health & Health Policy, City University of New York (CUNY), New York City, United States.
Vaccine information fatigue, exacerbated by the infodemic, misinformation, and cultural influences, hampers public responsiveness to the uptake of vaccines for COVID-19 and other vaccine-preventable diseases. This cross-sectional study of 23,000 respondents surveyed in 23 countries in October 2023 analyzed trust in information sources, perceptions of the pandemic's conclusion, and confidence in one's ability to discern false information from true and the association of these factors with willingness to pay attention to COVID-19 vaccine information, adjusting for sociodemographic characteristics. Results revealed that satisfaction with health authority communication was positively associated with individuals' willingness to pay attention to COVID-19 vaccine information in all 23 countries.
View Article and Find Full Text PDFApplied One Health: Nigeria National Veterinary Research Institute COVID-19 pandemic response.
Onderstepoort J Vet Res
September 2024
Department of Infectious and Transboundary Animal Diseases (ITADs), National Veterinary Research Institute, Vom Plateau State.
Article Synopsis
- - The COVID-19 pandemic has led to 7.1 million deaths globally, with Nigeria reporting its first case on February 27, 2020, resulting in 267,173 infections and 3,155 deaths by July 2024.
- - Initially, Nigeria had limited public health lab capabilities for COVID-19 diagnosis, but the National Veterinary Research Institute (NVRI) leveraged its resources and expertise to process over 33,000 samples across five states within six months.
- - Collaborative projects were established among NVRI, the Nigerian Centre for Disease Control, and other sectors, focusing on One Health grants to improve surveillance for coronaviruses and enhance pandemic preparedness through inter-sectoral cooperation.
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.
Diagnostics (Basel)
September 2024
Department of Obstetrics and Gynecology, Iuliu Hațieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
: Spontaneous remission of cancer is a rare and poorly understood phenomenon characterized by complete or partial remission of a malignancy in the absence of or with inadequate treatment. The underlying mechanism for such occurrences is poorly understood, however, immune mechanisms seem to play an important role in such cases. In recent years increasingly more data have become available in favor of the clinical benefit of low levels of chimerism in hematologic malignancies.
View Article and Find Full Text PDFComparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV).
Vaccine
December 2024
Bristol Trials Centre, University of Bristol, Bristol, UK.
Background: The ComFluCOV trial tested the safety and immunogenicity of COVID-19 and influenza vaccines co-administration. Binding and functional SARS-CoV2 anti-spike responses were measured using assays developed in response to the COVID-19 pandemic. The three assays used to measure the immunogenicity outcomes are reported here and their performance compared to inform future vaccine development.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!